Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | POGLUT2 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Poglut2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of KDELC1 mRNA | CTD | PMID:22206623 | POGLUT2 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Poglut2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of POGLUT2 mRNA | CTD | PMID:17942748 | POGLUT2 | Human | 17alpha-ethynylestradiol | decreases expression | ISO | Poglut2 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in decreased expression of POGLUT2 mRNA | CTD | PMID:17557909 | POGLUT2 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Poglut2 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of POGLUT2 mRNA | CTD | PMID:17555576 | POGLUT2 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Poglut2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | POGLUT2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of POGLUT2 mRNA | CTD | PMID:20106945 and PMID:21632981 | POGLUT2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Poglut2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of POGLUT2 mRNA | CTD | PMID:21570461 | POGLUT2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Poglut2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of POGLUT2 mRNA | CTD | PMID:17942748 | POGLUT2 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Poglut2 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of POGLUT2 protein | CTD | PMID:34915118 | POGLUT2 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA | CTD | PMID:28628672 | POGLUT2 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of POGLUT2 mRNA | CTD | PMID:32763439 | POGLUT2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of POGLUT2 gene | CTD | PMID:27153756 | POGLUT2 | Human | Aroclor 1254 | decreases expression | ISO | Poglut2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of POGLUT2 mRNA | CTD | PMID:23650126 | POGLUT2 | Human | benzo[a]pyrene | increases expression | ISO | Poglut2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of POGLUT2 mRNA | CTD | PMID:22228805 | POGLUT2 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA | CTD | PMID:28628672 | POGLUT2 | Human | bisphenol A | increases expression | ISO | Poglut2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of POGLUT2 mRNA | CTD | PMID:25181051 | POGLUT2 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of POGLUT2 mRNA | CTD | PMID:29275510 | POGLUT2 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA | CTD | PMID:28628672 | POGLUT2 | Human | carbon nanotube | increases expression | ISO | Poglut2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of POGLUT2 mRNA | CTD | PMID:25554681 | POGLUT2 | Human | celecoxib | affects expression | ISO | Poglut2 (Mus musculus) | 6480464 | Celecoxib affects the expression of POGLUT2 mRNA | CTD | PMID:20562220 | POGLUT2 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to KDELC1 gene] | CTD | PMID:28238834 | POGLUT2 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of POGLUT2 mRNA | CTD | PMID:20971185 | POGLUT2 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of POGLUT2 mRNA | CTD | PMID:20971185 | POGLUT2 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of POGLUT2 mRNA | CTD | PMID:19549813 | POGLUT2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of POGLUT2 mRNA | CTD | PMID:25562108 | POGLUT2 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA | CTD | PMID:28628672 | POGLUT2 | Human | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of POGLUT2 gene | CTD | PMID:22964155 | POGLUT2 | Human | dibutyl phthalate | decreases expression | ISO | Poglut2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of POGLUT2 mRNA | CTD | PMID:21266533 | POGLUT2 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of POGLUT2 mRNA | CTD | PMID:28302478 | POGLUT2 | Human | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of POGLUT2 mRNA | CTD | PMID:29803840 | POGLUT2 | Human | glafenine | increases expression | ISO | Poglut2 (Rattus norvegicus) | 6480464 | Glafenine results in increased expression of POGLUT2 mRNA | CTD | PMID:24136188 | POGLUT2 | Human | hydroquinone O-beta-D-glucopyranoside | increases expression | EXP | | 6480464 | Arbutin results in increased expression of POGLUT2 mRNA | CTD | PMID:17103032 | POGLUT2 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA | CTD | PMID:28628672 | POGLUT2 | Human | inulin | multiple interactions | ISO | Poglut2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDELC1 mRNA | CTD | PMID:36331819 | POGLUT2 | Human | iron atom | increases expression | EXP | | 6480464 | Iron deficiency results in increased expression of POGLUT2 mRNA | CTD | PMID:20368581 | POGLUT2 | Human | iron(0) | increases expression | EXP | | 6480464 | Iron deficiency results in increased expression of POGLUT2 mRNA | CTD | PMID:20368581 | POGLUT2 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of POGLUT2 protein | CTD | PMID:32959892 | POGLUT2 | Human | kojic acid | increases expression | EXP | | 6480464 | kojic acid results in increased expression of POGLUT2 mRNA | CTD | PMID:16595896 | POGLUT2 | Human | methapyrilene | decreases expression | ISO | Poglut2 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of POGLUT2 mRNA | CTD | PMID:30467583 | POGLUT2 | Human | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of POGLUT2 mRNA | CTD | PMID:22714537 | POGLUT2 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of POGLUT2 mRNA | CTD | PMID:22230336 | POGLUT2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Poglut2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDELC1 mRNA | CTD | PMID:36331819 | POGLUT2 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of POGLUT2 mRNA | CTD | PMID:21632981 | POGLUT2 | Human | serpentine asbestos | increases expression | EXP | | 6480464 | Asbestos and Serpentine results in increased expression of POGLUT2 mRNA | CTD | PMID:33581214 | POGLUT2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of POGLUT2 mRNA | CTD | PMID:22714537 | POGLUT2 | Human | tamoxifen | affects expression | ISO | Poglut2 (Mus musculus) | 6480464 | Tamoxifen affects the expression of POGLUT2 mRNA | CTD | PMID:17555576 | POGLUT2 | Human | tert-butyl hydroperoxide | decreases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in decreased expression of POGLUT2 mRNA | CTD | PMID:15336504 | POGLUT2 | Human | tetrachloromethane | increases expression | ISO | Poglut2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of POGLUT2 mRNA | CTD | PMID:31919559 | POGLUT2 | Human | thioacetamide | increases expression | ISO | Poglut2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of POGLUT2 mRNA | CTD | PMID:34492290 | POGLUT2 | Human | titanium dioxide | increases expression | ISO | Poglut2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of POGLUT2 mRNA | CTD | PMID:23409001 | POGLUT2 | Human | trovafloxacin | decreases expression | ISO | Poglut2 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of KDELC1 mRNA | CTD | PMID:35537566 | POGLUT2 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of POGLUT2 mRNA | CTD | PMID:28818685 | POGLUT2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of POGLUT2 mRNA | CTD | PMID:23179753 more ... | POGLUT2 | Human | valproic acid | affects expression | ISO | Poglut2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of POGLUT2 mRNA | CTD | PMID:17292431 | POGLUT2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of POGLUT2 mRNA | CTD | PMID:25979313 | POGLUT2 | Human | zoledronic acid | decreases expression | EXP | | 6480464 | Zoledronic Acid results in decreased expression of POGLUT2 mRNA | CTD | PMID:24714768 | |